Search Tag: SAH
2025 28 Apr
Non-traumatic subarachnoid haemorrhage (SAH) is a significant cause of death and disability globally, with an incidence of around 6 per 100,000 person-years. The initial treatment focuses on early aneurysm repair to prevent re-bleeding and reduce early brain injury risk. Management also addresses secondary brain injuries, including hydrocephalus, 1Read more
2025 10 Feb
Spontaneous aneurysmal subarachnoid haemorrhage (SAH) is a serious cerebrovascular event contributing significantly to morbidity and mortality. It is often associated with anaemia, which can worsen brain injury through cerebral hypoxia, particularly when haemoglobin (Hb) levels drop below 5 g/dL. In healthy brains, anaemia is compensated 1Read more
2025 10 Feb
Spontaneous aneurysmal subarachnoid haemorrhage (SAH) is a serious cerebrovascular event contributing significantly to morbidity and mortality. It is often associated with anaemia, which can worsen brain injury through cerebral hypoxia, particularly when haemoglobin (Hb) levels drop below 5 g/dL. In healthy brains, anaemia is compensated 1Read more
2023 30 Nov
Subarachnoid haemorrhage (SAH) carries a high disease-specific burden. Epidemiological studies have observed a reduction in the incidence of SAH from 1990 to 2019. However, the same trend was not observed for intrahospital mortality. Several studies focusing on the evaluation of SAH management across the world have shown a high heterogeneity in1Read more
2018 16 Mar
Hypothermia (HT) is a cornerstone of neuroprotective strategies and has been used in critical care for acutely brain injured adult patients for many years. This review aims to discuss the clinical evidence supporting the use of HT in neurocritical care patients beyond care after cardiac arrest (CA), such as traumatic brain injury (TBI), acute is1Read more